Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesRisk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations
Climacteric, 07/01/09
Schneider C et al. - The study provides evidence that estradiol/dydrogesterone use of several months to a few years is not associated with a higher risk of cardiovascular events than use of other HRT.
Related Articles
Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations
Climacteric, 11/16/09
Relevance Score: 80%
Today in Maternal Fetal Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Lifestyle Modification Program Decreases Pregnancy Weight Gain in Obese Women
American Journal of Perinatology, 12/17/09
Maternal Blood Pressure Adaptation in the First Trimester of Pregnancy
American Journal of Perinatology, 12/17/09
Maternal and neonatal morbidities associated with obstructive sleep apnea complicating pregnancy
American Journal of Obstetrics and Gynecology, 12/17/09
Today in Repro Endo - Infertility...keeping you current
Receive free subspecialty "5-minute updates" via email
The prevalence of abnormal cervical cytology in women with infertility
Diagnostic Cytopathology, 12/17/09
A new FSHbeta mutation in a 29 year-old woman with primary amenorrhea and isolated FSH deficiency: functional characterization and ovarian response to human recombinant FSH
European Journal of Endocrinology, 12/17/09
Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy
Human Reproduction, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor